Search results for "Intramuscular"

showing 10 items of 64 documents

Local skin necroses after intramuscular injection -Experimental animal studies-.

1977

The pathogenesis of local skin necroses after intramuscular injection of various drugs such as phenylbutazone (Embolia cutis medicamentosa, Nicolau's syndrome) is not clear. In an attempt to simulate this clinical feature experiments were performed on the rabbit ear lobe. A 20% phenylbutazone solution was injected paraarterial, intraarterial and paraarterial after perforation of the vessel. The drug produced a violent inflammation with all kinds of application. The local inflammation induced by paraarterial injection resulted in a fine scarring. Both other kinds of application produced necroses or even perforations. The histological examinations in these cases revealed massive destructions …

MalePathologymedicine.medical_specialtyNecrosisPerforation (oil well)InflammationDermatologyDermatitis ContactInjections IntramuscularSkin DiseasesPathogenesisLesionNecrosismedicinePhenylbutazoneAnimalsSkinbusiness.industryGeneral MedicineSurgerymedicine.anatomical_structurePhenylbutazoneBlood VesselsFemaleRabbitsmedicine.symptombusinessIntramuscular injectionmedicine.drugArteryArchives for dermatological research = Archiv fur dermatologische Forschung
researchProduct

Effect of legume grains as a source of dietary protein on the quality of organic lamb meat.

2011

BACKGROUND: This study evaluated the effects on lamb growth, carcass traits and meat quality of replacing conventional soybean meal in the diet with alternative legume grains. RESULTS: Twenty-eight male lambs of Comisana breed weighing 16.9 ± 2.7 kg at weaning (66 ± 6 days old) were assigned to one of four diets. Until slaughter at 129 ± 6 days of age, each group received ad libitum pelleted alfalfa hay and concentrates differing in the source of protein: chickpea, faba bean, pea or soybean meal. Lambs fed chickpea showed higher dry matter and protein intakes from concentrate than those fed soybean. Lambs' growth, carcass weight and net dressing percentage did not vary by protein source, al…

MaleSettore AGR/19 - Zootecnica SpecialeMeatAnimal feedanimal diseasesLinoleic acidConjugated linoleic acidSoybean mealpeaSensationBiologyWeight Gainfaba beansoybean mealchemistry.chemical_compoundchickpeamedicineFood QualityAnimalsHumansDry matterFood scienceLegumeSheep DomesticAdiposityNutrition and Dieteticsintramuscular fatty acid compositionlamb meatdigestive oral and skin physiologySeed Storage ProteinsPeasfood and beveragesFabaceaeAnimal FeedBreedCicerSettore AGR/02 - Agronomia E Coltivazioni ErbaceeVicia fabaTendernesschemistryItalySeedsFatty Acids UnsaturatedFood Organicmedicine.symptomAgronomy and Crop ScienceFood ScienceBiotechnologyAnimals Inbred StrainsJournal of the science of food and agriculture
researchProduct

Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up …

2018

Objective The objective of this study was to evaluate a quantitative method based on conventional T1-weighted magnetic resonance (MR) imaging to assess fatty muscular degeneration in patients with late-onset Pompe disease and to compare it with semi-quantitative visual evaluation (the Mercuri score). In addition, a long-term retrospective data analysis was performed to evaluate treatment response to enzyme replacement therapy with alglucosidase alfa. Methods MR images of the lumbar spine were acquired in 41 patients diagnosed with late-onset Pompe disease from 2006 through 2015. Two independent readers retrospectively evaluated fatty degeneration of the psoas and paraspinal muscles by apply…

MaleSupine position610 Medizinlcsh:MedicineBiochemistry030218 nuclear medicine & medical imagingDiagnostic RadiologyFatschemistry.chemical_compound0302 clinical medicine610 Medical sciencesMedicine and Health SciencesAge of Onsetlcsh:ScienceChildMusculoskeletal SystemObserver VariationMultidisciplinarymedicine.diagnostic_testbiologyGlycogen Storage Disease Type IIPharmaceuticsOrganic Compounds10042 Clinic for Diagnostic and Interventional RadiologyRadiology and ImagingMusclesEnzyme replacement therapyMuscle AnalysisMiddle AgedMagnetic Resonance ImagingLipidsChemistryBioassays and Physiological AnalysisAdipose TissuePhysical SciencesFemaleIntramuscular fatAnatomymedicine.drugResearch ArticleSpirometryAdultmedicine.medical_specialtyAdolescentImaging TechniquesUrologyMuscle Tissue610 Medicine & health1100 General Agricultural and Biological SciencesCreatineResearch and Analysis Methods03 medical and health sciencesYoung AdultDrug TherapyDiagnostic Medicine1300 General Biochemistry Genetics and Molecular BiologymedicineHumansEnzyme Replacement TherapyMuscle SkeletalAlglucosidase alfaAgedRetrospective Studies1000 Multidisciplinarybusiness.industrylcsh:ROrganic ChemistryChemical CompoundsBiology and Life SciencesMagnetic resonance imagingalpha-GlucosidasesCreatineBiological TissuechemistrySkeletal Musclesbiology.proteinlcsh:QCreatine kinasebusiness030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Anesthetic efficacy of ketamine-diazepam, ketamine-xylazine, and ketamine-acepromazine in Caspian Pond turtles (

2017

Objectives: The objective of this study was to assess the efficacy of different anesthetic drug combinations on the Caspian Pond turtles (Mauremys caspica). Subjects and Methods: Three groups of the Caspian Pond turtles (n = 6) were anesthetized with three different drug combinations. Initially, a pilot study was conducted to determine the best drug doses for the anesthetization of the turtles, and according to these results, ketamine–diazepam (120 mg/kg ketamine hydrochloride [5%] and 2 mg/kg diazepam [5%]), ketamine–acepromazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg acepromazine [1%]), and ketamine–xylazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg xylazine [2%]) wer…

MaleXylazineDiazepamTime FactorsDose-Response Relationship DrugketamineShort CommunicationPilot ProjectsInjections IntramuscularTurtlesSex FactorsAnesthesia Recovery PeriodAnimalsFemaleAcepromazineAnestheticsMauremys caspicaIndian journal of pharmacology
researchProduct

Anesthetic efficacy of ketamine-diazepam, ketamine-xylazine, and ketamine-acepromazine in Caspian Pond turtles (Mauremys caspica)

2017

Objectives: The objective of this study was to assess the efficacy of different anesthetic drug combinations on the Caspian Pond turtles (Mauremys caspica). Subjects and Methods: Three groups of the Caspian Pond turtles (n = 6) were anesthetized with three different drug combinations. Initially, a pilot study was conducted to determine the best drug doses for the anesthetization of the turtles, and according to these results, ketamine-diazepam (120 mg/kg ketamine hydrochloride [5%] and 2 mg/kg diazepam [5%]), ketamine-acepromazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg acepromazine [1%]), and ketamine-xylazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg xylazine [2%]) wer…

MaleXylazinePharmacologyDiazepamketamineDose-Response Relationship DrugTime FactorAnimalAnestheticSex FactorInjections IntramuscularTurtleAnesthesia Recovery PeriodFemalePilot ProjectPharmacology (medical)Mauremys caspicaAcepromazine
researchProduct

Leisure-time physical activity and high-risk fat: a longitudinal population-based twin study.

2009

Exercise is thought to reduce high-risk body fat, but intervention studies are frequently limited by short follow-ups and observational studies by genetic selection. Therefore, we studied the effects of a physically inactive vs active lifestyle on high-risk (visceral, liver and intramuscular) fat in twin pairs discordant for leisure-time physical activity habits for over 30 years.A longitudinal population-based twin study.Sixteen middle-aged (50-74 years) same-sex twin pairs (seven monozygotic (MZ), nine dizygotic (DZ)) with long-term discordance for physical activity habits were comprehensively identified from the Finnish Twin Cohort (TWINACTIVE study). Discordance was initially defined in…

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationLeisure timePhysical activityTwinsMedicine (miscellaneous)030209 endocrinology & metabolismPhysical exerciseIntra-Abdominal FatMotor Activity03 medical and health sciences0302 clinical medicineLeisure ActivitiesWeight lossRisk FactorsInternal medicineSurveys and QuestionnairesmedicineHumans030212 general & internal medicineLongitudinal StudiesObesityeducationFinlandAgededucation.field_of_studyNutrition and Dieteticsbusiness.industryMiddle Agedmedicine.diseaseTwin studyObesityMagnetic Resonance ImagingEndocrinologyFemaleIntramuscular fatmedicine.symptombusinessDemographyInternational journal of obesity (2005)
researchProduct

Leucocyte Interferon-alpha for Patients with Chronic Hepatitis C Intolerant to Other alpha-Interferons

2003

Background: Alpha-interferon (α-IFN) is the treatment of choice for chronic hepatitis C but most patients experience adverse effects which sometimes lead to the suspension of therapy. Recently, higher doses of α-IFN or prolonged therapy have increased the number of cases of intolerance. Study Design: In this open study we evaluated the efficacy and safety of leucocyte interferon-alpha (IFNα) [6MU three times a week] in 43 patients with chronic hepatitis C who had been intolerant to previous treatment courses with recombinant or lymphoblastoid IFNα. All patients were treated for 6 months and followed-up for an additional 6 months. End of treatment responders were patients in whom hepatitis C…

Malemedicine.medical_specialtyHepatitis C virusAlpha interferonmedicine.disease_causeAntiviral AgentsInjections IntramuscularGastroenterologyPharmacotherapyInternal medicineLeukocytesHumansImmunology and AllergyMedicinePharmacology (medical)Adverse effectPharmacologybiologybusiness.industryInterferon-alphaGeneral MedicineHepatitis C ChronicMiddle AgedMolecular medicineAnti-thyroid autoantibodiesDiscontinuationPharmacology Toxicology and Pharmaceutics (all)Immunologybiology.proteinFemaleAntibodybusinessBiotechnologyBioDrugs
researchProduct

Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction

2008

Aims In clinical studies on cell therapy for acute myocardial infarction (MI), cells are usually applied by intracoronary infusion with balloon (IC/B). To test the utility of balloon occlusion, mononuclear bone marrow cell (MNC) retention after intracoronary infusion without balloon (IC/noB) was compared with IC/B and intramyocardial (IM) injection. Methods and results Four hours after LAD ligation in male pigs, reperfusion was allowed (confirmed by coronary angiography). Five days later, 1 × 108 autologous 111Indium-labelled MNC were injected IC/noB ( n = 4), IC/B ( n = 4), or IM ( n = 4). At 1 h the fraction of injected MNC that was detected in the heart was 4.1 ± 1.1% after IC/noB inject…

Malemedicine.medical_specialtyPathologySwineMyocardial InfarctionUrologyBone Marrow CellsMyocardial ReperfusionCoronary AngiographyBalloonPeripheral blood mononuclear cellReperfusion therapySuidaemedicineAnimalsMyocardial infarctionBone Marrow TransplantationMicroscopy Confocalbiologybusiness.industryBalloon Occlusionmedicine.diseasebiology.organism_classificationmedicine.anatomical_structureInjections Intra-ArterialCirculatory systemBone marrowCardiology and Cardiovascular MedicinebusinessIntramuscular injectionTomography Emission-ComputedEuropean Heart Journal
researchProduct

Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inf…

2015

AbstractZostavax® is a live, attenuated varicella zoster virus (VZV) vaccine developed specifically for the prevention of HZ and PHN in individuals aged ≥50 years. During the clinical development of Zostavax, which was mainly in the US, the vaccine was administrated by the subcutaneous (SC) route. In Europe, many healthcare professionals prefer administering vaccines by the intramuscular (IM) route. This was an open-label, randomised trial conducted in 354 subjects aged ≥50 years. The primary objectives were to demonstrate that IM administration is both non-inferior to SC administration in terms of 4-week post-vaccination geometric mean titres (GMTs), and elicits an acceptable geometric mea…

Malemedicine.medical_specialtySub-cutaneous administration routeEnzyme-Linked Immunospot AssayHerpesvirus 3 HumanInjections SubcutaneousVaricella zoster virus vaccinePainmedicine.disease_causeAntibodies ViralVaccines AttenuatedHerpes ZosterInjections Intramuscularlaw.inventionShinglesInterferon-gammaRandomized controlled triallawImmunology and Microbiology(all)Internal medicinemedicineEdemaHerpes Zoster VaccineHumansAdverse effectAgedRandomised controlled trialAged 80 and overAttenuated vaccineIntention-to-treat analysisGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryELISPOTImmunogenicityVaccinationPublic Health Environmental and Occupational HealthVaricella zoster virusIntramuscular administration routeMiddle Agedmedicine.diseaseveterinary(all)Infectious DiseasesErythemaImmunologyMolecular MedicineFemalebusinessShinglesVaccine
researchProduct

Efficacy of systemic administration of riboflavin on a rabbit model of corneal alkali burn

2020

AbstractChanges in the barrier mechanisms in the eye should determine the rational route for the administration and dosage of each drug in the treatment of traumatic injuries and other pathologies. The aim of this study was to examine the efficacy of intra-arterial delivery of 14C-riboflavin (as an “indicator”) and compare it with intravenous and intramuscular administration in an animal model of chemical eye burn. 14C-riboflavin (14C-I) was administered by intra-arterial (carotid artery), intravenous (femoral vein) and intramuscular (femoral muscle) routes. The total radioactivity was determined over 2 h in the plasma and structures of the rabbit’s eyes using a scintillation counter. The r…

Malemedicine.medical_specialtygenetic structuresRiboflavinFemoral veinlcsh:MedicineAlkaliesAdministration CutaneousInjections Intramuscular030226 pharmacology & pharmacyArticleCornea03 medical and health sciencesRoute of administrationMedical research0302 clinical medicineCiliary bodyOphthalmologyCorneaBurns ChemicalmedicineAnimalsHumanslcsh:ScienceMultidisciplinarybusiness.industryAqueous humourlcsh:Reye diseasesScleraDisease Models AnimalEye Burnsmedicine.anatomical_structureInjections Intra-ArterialOutcomes research030221 ophthalmology & optometrySystemic administrationlcsh:QFemaleRabbitssense organsChoroidbusinessCorneal InjuriesScientific Reports
researchProduct